Of note, two-dimensional culture of human melanoma cells with DCs revealed that prostaglandin E2 and IL-6 released from the melanoma cells converted cDC2s into CD14+ cDCs, which are characterized by an immunosuppressive phenotype [82]. This evidence concerns the gene CD14 and melanoma.